Tradestie Institutional Equity Comparison Engine
ARIA vs GERN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GERN Overall Edge
GERN Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Geron Corp (GERN) driven by superior Valuation, Growth & Margin, Options & Structure while ARIA counters with relative strength in Momentum & Technical. Fundamentally, ARIA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus GERN at 48.3x Forward P/E and -7.2% operating margin (+27.4% YoY). In options structure, ARIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GERN sits in BREAKDOWN (17th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
GERN
ARIA N/M vs GERN 48.3x Fwd P/E
Growth & Margin Winner
GERN
Op Margin N/A vs -7.2% ยท YoY N/A vs +27.4%
Momentum & Technical Winner
ARIA
1Y -17.0% vs -18.1% ยท 52W Pos 0% vs 9%
Options & Structure Winner
GERN
UNCLASSIFIED (N/A IV) vs BREAKDOWN (17th %ile IV)
ARIA
US Equity
ARIA
Institutional Equity
$21.03
-3.52% 1D
Market Cap
N/A
1M Return
-11.55%
1Y Return
-16.97%
Forward P/E
N/M
Unified AI Score
47.7 / 100
HOLD
Tech 50.0
Fund 52.0
Flow 50.0
Mom 60.0
GERN
NASDAQ
Geron Corp
Pharmaceutical Preparations
$0.94
-2.6% 1D
Market Cap
$623.0M
1M Return
-19.5%
1Y Return
-18.1%
Forward P/E
48.3x
Unified AI Score
54.1 / 100
HOLD
Tech 69.0
Fund 70.0
Flow 71.0
Mom 68.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ARIA -16.97%
GERN -18.1%
Spread: +19.39 pp (ARIA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ARIA TTM Op. Margin: N/A
GERN TTM Op. Margin: -7.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARIA vs GERN. Trailing 12-month operating profitability (ARIA N/A vs GERN -7.2%) and valuation multiples (ARIA N/M vs GERN 48.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ARIA | GERN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $623.0M | Larger Scale | GERN |
| Trailing P/E Ratio Valuation | N/M | 48.3x | Lower Multiple | GERN |
| Forward P/E Ratio Valuation | N/M | 48.3x | Lower Multiple | GERN |
| Revenue Growth (YoY) Growth | N/A | +27.4% | Higher Growth | GERN |
| Operating Margin (TTM) Profitability | N/A | -7.2% | Higher Margin | GERN |
| Net Profit Margin Profitability | N/A | -22.0% | Higher Margin | GERN |
| Return on Equity (ROE) Capital Efficiency | N/A | -20.1% | Higher ROE | GERN |
| 52-Week Range Position Momentum | 0% ($21โ$27) | 9% ($1โ$2) | Stronger Trend | GERN |
| Beta / 30D Volatility Risk Regime | 1.92ฮฒ ยท 43% Vol | 1.53ฮฒ ยท 101% Vol | Lower Realized Risk | ARIA |
| Unified Institutional Score Composite Signal | 47.7 / 100 (HOLD) | 54.1 / 100 (HOLD) | Higher Composite | GERN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ARIA vs GERN Buy Guide
ARIA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
GERN
BREAKDOWN
72d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
17th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ARIA nor GERN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.